Morgan Stanley Reneo Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 64,523 shares of RPHM stock, worth $108,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,523

Previous 198,518 67.5%

Holding current value

$108,398

Previous $299,000 63.55%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.34 - $1.7 $179,553 - $227,791	-133,995 Reduced 67.5%	64,523 $109,000
Q2 2024 Oct 17, 2024	SELL	$1.51 - $1.9 $43,247 - $54,417	-28,641 Reduced 12.61%	198,518 $299,000
Q2 2024 Aug 14, 2024	SELL	$1.51 - $1.9 $43,247 - $54,417	-28,641 Reduced 12.61%	198,518 $299,000
Q1 2024 Oct 17, 2024	BUY	$1.59 - $1.74 $45,539 - $49,835	28,641 Added 14.43%	227,159 $377,000
Q1 2024 Aug 16, 2024	BUY	$1.59 - $1.74 $162,552 - $177,887	102,234 Added 81.84%	227,159 $377,000
Q1 2024 May 15, 2024	BUY	$1.59 - $1.74 $162,552 - $177,887	102,234 Added 81.84%	227,159 $377,000
Q4 2023 Aug 16, 2024	SELL	$1.34 - $8.43 $98,614 - $620,388	-73,593 Reduced 37.07%	124,925 $199,000
Q4 2023 Feb 13, 2024	BUY	$1.34 - $8.43 $124,093 - $780,677	92,607 Added 286.55%	124,925 $199,000
Q3 2023 Nov 15, 2023	SELL	$5.44 - $8.13 $18,729 - $27,991	-3,443 Reduced 9.63%	32,318 $246,000
Q2 2023 Aug 14, 2023	SELL	$5.44 - $10.5 $35,729 - $68,964	-6,568 Reduced 15.52%	35,761 $234,000
Q1 2023 May 15, 2023	BUY	$2.44 - $6.42 $6,734 - $17,719	2,760 Added 6.98%	42,329 $253,000
Q4 2022 Feb 14, 2023	SELL	$1.8 - $3.52 $570 - $1,115	-317 Reduced 0.79%	39,569 $92,000
Q3 2022 Nov 14, 2022	BUY	$2.35 - $4.85 $45,568 - $94,046	19,391 Added 94.61%	39,886 $134,000
Q2 2022 Oct 27, 2022	BUY	$1.96 - $3.04 $29,568 - $45,861	15,086 Added 278.91%	20,495 $54,000
Q2 2022 Aug 15, 2022	BUY	$1.96 - $3.04 $29,568 - $45,861	15,086 Added 278.91%	20,495 $54,000
Q1 2022 Oct 27, 2022	SELL	$2.94 - $9.07 $44,352 - $136,830	-15,086 Reduced 73.61%	5,409 $16,000
Q1 2022 May 13, 2022	SELL	$2.94 - $9.07 $5,112 - $15,772	-1,739 Reduced 24.33%	5,409 $16,000
Q4 2021 Feb 14, 2022	BUY	$6.07 - $9.68 $18,137 - $28,923	2,988 Added 71.83%	7,148 $61,000
Q3 2021 Nov 15, 2021	BUY	$6.28 - $11.07 $26,124 - $46,051	4,160 New	4,160 $30,000

Others Institutions Holding RPHM

# of Institutions

Shares Held

31M

Call Options Held

50.8K

Put Options Held

View Full List

About Reneo Pharmaceuticals, Inc.

Ticker RPHM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,479,600
Market Cap $41.1M
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...

More about RPHM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account